Abstract
Oral mucositis is one of the most common and distressing side effects of cancer therapy and results from damage to the mucosal lining of the gastrointestinal tract due to radiation therapy and chemotherapy. Mucositis is characterized by oral erythema, ulceration, and pain and is seen as a continuum from limited patches of mildly sore erythematous mucosae to diffuse areas of painful ulceration and pseudomembranes. The oncology health care team must proactively assess and manage the oral health of pediatric oncology patients before, during and after cancer therapy. This chapter describes the incidence, etiologies, and treatments of oral mucositis and summarizes general oral health care for pediatric oncology patients. Current evidence-based guidelines are reviewed in order to aid pediatric oncology practitioners on best practice for the oral health of their patients.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abramoff MM, Lopes NN, Lopes LA et al (2008) Low-level laser therapy in the prevention and treatment of chemotherapy-induced oral mucositis in young patients. Photomed Laser Surg 26:393–400
Allen G, Logan R, Gue S (2010) Oral manifestations of cancer treatment in children: a review of the literature. Clin J Oncol Nurs 14:481–490
American Academy of Pediatric Dentistry (2013) Guideline on dental management of pediatric patients receiving chemotherapy, hematopoietic stem cell transplantation, and/or radiation. Pediatr Dent 35:E185–E193
Anderson PM, Schroeder G, Skubitz KM (1998) Oral glutamine reduces the duration and severity of stomatitis after cytotoxic cancer chemotherapy. Cancer 83:1433–1439
Aquino VM, Harvey AR, Garvin JH et al (2005) A double-blind randomized placebo-controlled study of oral glutamine in the prevention of mucositis in children undergoing hematopoietic stem cell transplantation: a pediatric blood and marrow transplant consortium study. Bone Marrow Transplant 36:611–616
Barasch A, Epstein J, Tilashalski K (2009) Palifermin for management of treatment-induced oral mucositis in cancer patients. Biol Targets Ther 3:111–116
Bensadoun RJ, Nair RG (2012) Low-level laser therapy in the prevention and treatment of cancer therapy-induced mucositis: 2012 state of the art based on literature review and meta-analysis. Curr Opin Oncol 24:363–370
Bjordal JM (2012) Low level laser therapy (LLLT) and World Association for Laser Therapy (WALT) dosage recommendations. Photomed Laser Surg 30:61–62
Chen CF, Wang RH, Cheng SN, Chang YC (2004) Assessment of chemotherapy-induced oral complications in children with cancer. J Pediatr Oncol Nurs 21:33–39
Cheng KK, Lee V, Li CH et al (2012) Oral mucositis in pediatric and adolescent patients undergoing chemotherapy: the impact of symptoms on quality of life. Support Care Cancer 20:2335–2342
Clarkson JE, Eden OB (1998) Dental health in children with cancer. Arch Dis Child 78:560–561
Clarkson JE, Worthington HV, Eden OB (2007) Interventions for preventing oral candidiasis for patients with cancer receiving treatment. Cochrane Database Syst Rev 1:CD003807
Clarkson JE, Worthington HV, Furness S et al (2010) Interventions for treating oral mucositis for patients with cancer receiving treatment. Cochrane Database Syst Rev (4):CD001973
Cruz LB, Ribeiro AS, Rech A et al (2007) Influence of low-energy laser in the prevention of oral mucositis in children with cancer receiving chemotherapy. Pediatr Blood Cancer 48:435–440
Eilers J, Million R (2011) Clinical update: prevention and management of oral mucositis in patients with cancer. Semin Oncol Nurs 27:e1–e16
Eilers J, Berger AM, Petersen MC (1988) Development, testing, and application of the oral assessment guide. Oncol Nurs Forum 15:325–330
Glenny AM, Fernandez Mauleffinch LM, Pavitt S, Walsh T (2009) Interventions for the prevention and treatment of herpes simplex virus in patients being treated for cancer. Cochrane Database Syst Rev 1:CD006706
Glenny AM, Gibson F, Auld E (2010) The development of evidence-based guidelines on mouth care for children, teenagers and young adults treated for cancer. Eur J Cancer 46:1399–1412
Guyatt G, Gutterman D, Baumann MH et al (2006) Grading strength of recommendations and quality of evidence in clinical guidelines: report from an American College of Chest Physicians Task Force. Chest 129:174–181
Jacobs S, Baggott C, Agarwal R et al (2013) Validation of the Children’s International Mucositis Evaluation Scale (ChIMES) in paediatric cancer and SCT. Br J Cancer 109:2515–2522
Keefe DM, Gibson RJ (2007) Mucosal injury from targeted anti-cancer therapy. Support Care Cancer 15:483–490
Kuhn A, Porto FA, Miraglia P, Brunetto AL (2009) Low-level infrared laser therapy in chemotherapy-induced oral mucositis: a randomized placebo-controlled trial in children. J Pediatr Hematol Oncol 31:33–37
Lalla RV, Sonis ST, Peterson DE (2008) Management of oral mucositis in patients who have cancer. Dent Clin North Am 52:61–77, viii
Lalla RV, Latortue MC, Hong CH et al (2010) A systematic review of oral fungal infections in patients receiving cancer therapy. Support Care Cancer 18:985–992
Langner S, Staber PB, Schub N et al (2008) Palifermin reduces incidence and severity of oral mucositis in allogeneic stem-cell transplant recipients. Bone Marrow Transplant 42:275–279
Lauritano D, Petruzzi M, Di Stasio D, Lucchese A (2014) Clinical effectiveness of palifermin in prevention and treatment of oral mucositis in children with acute lymphoblastic leukaemia: a case-control study. Int J Oral Sci 6:27–30
McDonnell AM, Lenz KL (2007) Palifermin: role in the prevention of chemotherapy- and radiation-induced mucositis. Ann Pharmacother 41:86–94
Posner MR, Haddad RI (2007) Novel agents for the treatment of mucositis. J Support Oncol 5:33–39
Rubenstein EB, Peterson DE, Schubert M et al (2004) Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis. Cancer 100:2026–2046
Scully C, Epstein J, Sonis S (2003) Oral mucositis: a challenging complication of radiotherapy, chemotherapy, and radiochemotherapy: part 1, pathogenesis and prophylaxis of mucositis. Head Neck 25:1057–1070
Scully C, Sonis S, Diz PD (2006) Oral mucositis. Oral Dis 12:229–241
Sonis ST (2004) A biological approach to mucositis. J Support Oncol 2:21–32
Sonis ST (2009) Mucositis: the impact, biology and therapeutic opportunities of oral mucositis. Oral Oncol 45:1015–1020
Sonis ST (2011) Oral mucositis. Anticancer Drugs 22:607–612
Sonis ST, Eilers JP, Epstein JB (1999) Validation of a new scoring system for the assessment of clinical trial research of oral mucositis induced by radiation or chemotherapy. Mucositis Study Group. Cancer 85:2103–2113
Sonis ST, Elting LS, Keefe D (2004) Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients. Cancer 100:1995–2025
Sonis ST (2007) Pathobiology of oral mucositis: novel insights and opportunities. J Support Oncol 5:3–11
Spielberger R, Stiff P, Bensinger W et al (2004) Palifermin for oral mucositis after intensive therapy for hematologic cancers. N Engl J Med 351:2590–2598
Srinivasan A, Kasow KA, Cross S et al (2012) Phase I study of the tolerability and pharmacokinetics of palifermin in children undergoing allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 18:1309–1314
Storey B (2007) The role of oral glutamine in pediatric bone marrow transplant. J Pediatr Oncol Nurs 24:41–45
Sung L, Tomlinson GA, Greenberg ML et al (2007) Validation of the oral mucositis assessment scale in pediatric cancer. Pediatr Blood Cancer 49:149–153
Tomlinson D, Judd P, Hendershot E et al (2007) Measurement of oral mucositis in children: a review of the literature. Support Care Cancer 15:1251–1258
Tomlinson D, Gibson F, Treister N et al (2008a) Challenges of mucositis assessment in children: expert opinion. Eur J Oncol Nurs 12:469–475
Tomlinson D, Isitt JJ, Barron RL et al (2008b) Determining the understandability and acceptability of an oral mucositis daily questionnaire. J Pediatr Oncol Nurs 25:107–111
Tomlinson D, Judd P, Hendershot E et al (2008c) Establishing literature-based items for an oral mucositis assessment tool in children. J Pediatr Oncol Nurs 25:139–147
Tomlinson D, Gibson F, Treister N et al (2009) Understandability, content validity, and overall acceptability of the Children’s International Mucositis Evaluation Scale (ChIMES): child and parent reporting. J Pediatr Hematol Oncol 31:416–423
Tomlinson D, Gibson F, Treister N et al (2010) Refinement of the Children’s International Mucositis Evaluation Scale (CHiMES): child and parent perspectives on understandability, content validity and acceptability. Eur J Oncol Nurs 14:29–41
Tomlinson D, Ethier MC, Judd P et al (2011) Reliability and construct validity of the oral mucositis daily questionnaire in children with cancer. Eur J Cancer 47:383–388
Treister N, Sonis S (2007) Mucositis: biology and management. Curr Opin Otolaryngol Head Neck Surg 15:123–129
Vitale KM, Violago L, Cofnas P et al (2014) Impact of palifermin on incidence of oral mucositis and healthcare utilization in children undergoing autologous hematopoietic stem cell transplantation for malignant diseases. Pediatr Transplant 18:211–216
Ware E, Smith M, Henderson M et al (2009) The effect of high-dose enteral glutamine on the incidence and severity of mucositis in paediatric oncology patients. Eur J Clin Nutr 63:134–140
Worthington HV, Clarkson JE, Khalid T et al (2010) Interventions for treating oral candidiasis for patients with cancer receiving treatment. Cochrane Database Syst Rev 7:CD001972
Worthington HV, Clarkson JE, Bryan G et al (2011) Interventions for preventing oral mucositis for patients with cancer receiving treatment. Cochrane Database Syst Rev 4:CD000978
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Berlin Heidelberg
About this chapter
Cite this chapter
Mills, D., Maloney, A.M. (2015). Oral Mouth Care and Mucositis. In: Feusner, J., Hastings, C., Agrawal, A. (eds) Supportive Care in Pediatric Oncology. Pediatric Oncology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-44317-0_11
Download citation
DOI: https://doi.org/10.1007/978-3-662-44317-0_11
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-44316-3
Online ISBN: 978-3-662-44317-0
eBook Packages: MedicineMedicine (R0)